Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131I-metaiodobenzylguanidine
European Journal of Cancer2016Vol. 66, pp. 144–152
Citations Over TimeTop 15% of 2016 papers
K. Huibregtse, Kieuhoa T. Vo, Steven G. DuBois, Stephanie Fetzko, John Neuhaus, Vandana Batra, John M. Maris, Brian Weiss, Araz Marachelian, Greg Yanik, Katherine K. Matthay
Related Papers
- → Anthracycline-Induced Clinical Heart Failure in a Cohort of 607 Children: Long-Term Follow-Up Study(2001)398 cited
- → Clinical heart failure in a cohort of children treated with anthracyclines: A long-term follow-up study(2006)282 cited
- → Allogeneic cord blood transplantation for adult acute lymphoblastic leukemia: retrospective survey involving 256 patients in Japan(2012)32 cited
- → [The relationship between hazard ratio and median survival time].(2019)
- → 059 Secondary progressive MS in the UK: a prospective cohort study(2022)